Influenza vaccine effectiveness in patients on hemodialysis: An analysis of a natural experiment

Archives of Internal Medicine

Volumn 172, Issue 7, 2012, Pages 548-554

  McGrath, Leah J ^a   Kshirsagar, Abhijit V ^b   Cole, Stephen R ^a   Wang, Lily ^b   Weber, David J ^a,b   Stürmer, Til ^a   Brookhart, M Alan ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADJUVANT THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HAZARD RATIO; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFLUENZA; KIDNEY FAILURE; MALE; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; UNITED STATES;

ADULT; AGED; BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; SEASONS; UNITED STATES; VACCINATION;

EID: 84859710807     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.2238     Document Type: Article

References (31)

1. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165(3):265-272. (Pubitemid 40216277)
2. Eickhoff TC. Immunization against influenza: rationale and recommendations. J Infect Dis. 1971;123(4):446-454.
3. Vogtländer NPJ, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus ADME. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine. 2004;22(17-18):2199-2201. (Pubitemid 38626058)
4. Brydak LB, Roszkowska-Blaim M, Machala M, Leszczyńska B, Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine. 2000;18(28):3280- 3286. (Pubitemid 30408204)
5. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009;9(8):493-504.
6. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int. 2003;63(2):738-743. (Pubitemid 36126822)
7. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373-1381. (Pubitemid 47535592)
8. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130(5):397-403. (Pubitemid 29111221)
9. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348(14):1322-1332. (Pubitemid 36384099)
10. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35(2):345-352.
11. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006; 35(2):337-344.
12. Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet. 2008; 372(9636):398-405.
13. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658-666. (Pubitemid 47444564)
14. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010;28(45):7267-7272.
15. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine. MMWR Morb Mortal Wkly Rep. 1998;47(14):280-284.
16. Centers for Disease Control and Prevention. Update: influenza activity - United States, 1997-98 season. MMWR Morb Mortal Wkly Rep. 1998;47(10):196- 200.
17. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284(13):1655-1663.
18. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine. MMWR Morb Mortal Wkly Rep. 1999;48(18):374-378.
19. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2000;49(17):375-381.
20. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 2001-02 season, and composition of the 2002-03 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2002;51(23):503-506.
21. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2001;50(22):466-479.
22. Lindsay L, Jackson LA, Savitz DA, et al. Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women. Am J Epidemiol. 2006;163(9):838-848.
23. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int. 2010;77(2): 141-151.
24. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
25. Efron B. The efficiency of Cox's likelihood function for censored data. J AmStat Assoc. 1977;72(359):557-565.
26. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.
27. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166(3):348-354. (Pubitemid 47216808)
28. Fernández-Fresnedo G, Ramos MA, González-Pardo MC, de Francisco ALM, López- Hoyos M, Arias M. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000;15(4): 502-510. (Pubitemid 30160657)
29. Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl. February 2001;(78):S206-S211. (Pubitemid 32144099)
30. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650-656.
31. Dikow R, Eckerle I, Ksoll-Rudek D, et al. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial. Am J Kidney Dis. 2011;57(5):716-723.